Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Novel Preparations of Glucagon for the Prevention and Treatment of Hypoglycemia.
Curr Diab Rep. 2019 Sep 6;19(10):97. doi: 10.1007/s11892-019-1216-4.
Curr Diab Rep. 2019.
PMID: 31493043
Free PMC article.
Review.
PURPOSE OF REVIEW: New more stable formulations of glucagon have recently become available, and these provide an opportunity to expand the clinical roles of this hormone in the prevention and management of insulin-induced hypoglycemia. This is applicable in type 1 diabetes, hy …
PURPOSE OF REVIEW: New more stable formulations of glucagon have recently become available, and these provide an opportunity to expand the c …
Photobiomodulation Therapy on the Treatment of Insulin Resistance: A Narrative Review.
Magalhães FC, Ferraresi C.
Magalhães FC, et al.
Photobiomodul Photomed Laser Surg. 2022 Sep;40(9):597-603. doi: 10.1089/photob.2022.0031. Epub 2022 Aug 30.
Photobiomodul Photomed Laser Surg. 2022.
PMID: 36040371
Review.
Photobiomodulation therapy (PBMT) is another noninvasive and nonpharmacological therapy, which produces positive effects on mitochondrial metabolism, oxidative stress, and inflammation generally linked to IR and DM2 and may improve or attenuate the severity of these …
Photobiomodulation therapy (PBMT) is another noninvasive and nonpharmacological therapy, which produces positive effects on mi …
Item in Clipboard
Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.
Kapoor RR, James C, Hussain K.
Kapoor RR, et al.
Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):101-12. doi: 10.1038/ncpendmet1046.
Nat Clin Pract Endocrinol Metab. 2009.
PMID: 19165222
Review.
Mutations in HNF4A, GLUD1, CGK, and HADH lead to transient or persistent HH, whereas mutations in SLC16A1 cause exercise-induced HH. Rapid genetic analysis combined with an understanding of the histological features (focal or diffuse disease) of congenital HH and th …
Mutations in HNF4A, GLUD1, CGK, and HADH lead to transient or persistent HH, whereas mutations in SLC16A1 cause exercise-induced …
Item in Clipboard
Simulation-Based Evaluation of Treatment Adjustment to Exercise in Type 1 Diabetes.
Deichmann J, Bachmann S, Burckhardt MA, Szinnai G, Kaltenbach HM.
Deichmann J, et al.
Front Endocrinol (Lausanne). 2021 Aug 19;12:723812. doi: 10.3389/fendo.2021.723812. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34489869
Free PMC article.
Regular exercise is beneficial and recommended for people with type 1 diabetes, but increased glucose demand and changes in insulin sensitivity require treatment adjustments to prevent exercise-induced hypoglycemia. Several different adjustment strategies based on i …
Regular exercise is beneficial and recommended for people with type 1 diabetes, but increased glucose demand and changes in insulin sensitiv …
Item in Clipboard
Cite
Cite